Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixekizumab in Pityriasis Rubra Pilaris (PRP)
NCT03485976Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- May 2018
- Primary completion
- Oct 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ixekizumab in pityriasis rubra pilaris (PRP), sponsored by Oregon Health & Science University. Started May 2018; status: completed.
02
Drugs
ixekizumab
03
Conditions
pityriasis rubra pilaris (PRP)
Beyond the preview
Go deeper on NCT03485976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485976.